Yogatel 40 Tablet contains Telmisartan 40 mg, an angiotensin II receptor antagonist primarily used for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Telmisartan effectively reduces vasoconstriction and aldosterone secretion, leading to decreased blood pressure and improved cardiovascular outcomes. Yogatel 40 is indicated for the treatment of essential hypertension, helping to lower elevated blood pressure and thereby reducing the risk of stroke, myocardial infarction, and other cardiovascular complications. It may also be prescribed for patients with left ventricular hypertrophy or those at high risk of cardiovascular events. The tablet is typically administered once daily, with or without food, and dosage adjustments should be based on clinical response and tolerability. Common adverse effects include dizziness, headache, and fatigue, while serious side effects are rare but may involve hypotension, hyperkalemia, or renal impairment. Caution is advised in patients with renal or hepatic dysfunction, and it is contraindicated during pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Yogatel 40 offers an effective and well-tolerated option for long-term blood pressure control under medical supervision.